Use of high density gene arrays for gene expression profiling and genotyping

Genomics: Fundamentals and Applications

Volumn , Issue , 2008, Pages 131-134

  Jackson, Scott A ^a   Patel, Isha ^a   LeClerc, J Eugene ^a   Cebula, Thomas A ^a   Mammel, Mark K ^a   Kotewicz, Michael L ^a   Mukherjee, Amit ^a   Mahata, Sushil K ^b,c   Flores, Juan L Rodriguez ^b   Mahata, Manjula ^b   O ‘Connor, Daniel T ^b   Srinivasan, Jannavi R ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882252303     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (79)

1. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-517.
2. Pease AC, Solas D, Sullivan EJ, et al. Light-generated oligonucleotide arrays for rapid DNA sequence analysis. Proc Natl Acad Sci USA 1994; 91: 5022-5026.
3. Nuwaysir EF, Huang W, Albert TJ, et al. Gene expression analysis using oligonucleotide arrays produced by maskless photolithography. Genome Res 2002; 12: 1749-1755.
4. Ronaghi M. Pyrosequencing sheds light on DNA sequencing. Genome Res 2001; 11: 3-11.
5. Cebula TA, Brown EW, Jackson SA, et al. Molecular applications for identifying microbial pathogens in the post-9/11 era. Expert Rev Mol Diagn 2005; 5: 431-445.
6. Danna K, Nathans D. Specific cleavage of Simian Virus 40 DNA by restriction endonuclease of Hemophilus Influenzae. Proc Nat Acad Sci USA 1971; 68: 2913-2917.
7. Meng X, Benson K, Chada K, et al. Optical mapping of lambda bacteriophage clones using restriction endonucleases. Nat Genet 1995; 9: 432-438.
8. Ferris MM, Yoshida TM, Marrone BL, et al. Fingerprinting of single viral genomes. Anal Biochem 2005; 337: 278-288.
9. Jing J, Reed J, Huang J, et al. Automated high resolution optical mapping using arrayed, fluid-fixed DNA molecules. Proc Nat Acad Sci USA 1998; 95: 8046-8051.
10. Lin J, Qi R, Aston C, et al. Whole-genome shotgun optical mapping of Deinococcus radiodurans. Science 1999; 285: 1558-1562.
11. Lim A, Dimalanta ET, Potamousis KD, et al. Shotgun optical maps of the whole Escherichia coli O157:H7 genome. Genome Res 2001; 11: 1584-1593.
12. Bochner BR, Gadzinski P, Panomitros E. Phenotype microarrays for high-throughput phenotypic testing and assay of gene function. Genome Res 2001; 11: 1246-1255.
13. Bochner BR. New technologies to assess genotype-phenotype relationships. Nat Rev Genet 2003; 4: 309-314.
14. Zhou L, Lei XH, Bochner BR, et al. Phenotype microarray analysis of Escherichia coli K-12 mutants with deletions of all two-component systems. J Bacteriol 2003; 185: 4956-4972.
15. Sanger F, Coulson AR. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol 1975; 94: 441-448.
16. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
17. Maxam AM, Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci USA 1977; 74: 560-564.
18. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-517.
19. Tibanyenda N, De Bruin SH, Haasnoot CA, et al. The effect of single base-pair mismatches on the duplex stability of d(T-A-T-T-A-A-T-A-T-C-A-A-G-T-T-G). d(C-A-A-C-T-T-G-A-T-A-TT-A-A-T-A). Eur J Biochem 1984; 139: 19-27.
20. Ronaghi M, Karamohamed S, Pettersson B, et al. Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 1996; 242: 84-89.
21. Ronaghi M, Uhlen M, Nyren P. A sequencing method based on real-time pyrophosphate. Science 1998; 281: 363-365.
22. Nyren P, Lundin A. Enzymatic method for continuous monitoring of inorganic pyrophosphate synthesis. Anal Biochem 1985; 151: 504-509.
23. Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005; 437: 376-380.
24. Ronaghi M, Nygren M, Lundeberg J, et al. Analyses of secondary structures in DNA by pyrosequencing. Anal Biochem 1999; 267: 65-71.
25. Karamohamed S, Nilsson J, Nourizad K, et al. Production, purification, and luminometric analysis of recombinant Saccharomyces cerevisiae MET3 adenosine triphosphate sulfurylase expressed in Escherichia coli. Protein Expr Purif 1999; 15: 381-388.
26. de Wet JR, Wood KV, Helinski DR, et al. Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli. Proc Natl Acad Sci USA 1985; 82: 7870-7873.
27. Rao F, Wen G, Gayen JR, et al. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation 2007; 115: 2271-2281.
28. Rao F, Zhang L, Wessel J, et al. Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. Circulation 2007; 116: 993-1006.
29. Fung MM, Nguyen C, Mehtani P, et al. Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans. Circulation 2008; 117: 517-525.
30. Zhang L, Rao F, Zhang K, et al. Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk. J Clin Invest 2007; 117: 2658-2671.
31. Lillie EO, Mahata M, Khandrika S, et al. Heredity of endothelin secretion: human twin studies reveal the influence of polymorphism at the chromogranin A locus, a novel determinant of endothelial function. Circulation 2007; 115: 2282-2291.
32. Salem RM, Cadman PE, Chen Y, et al. Chromogranin A polymorphisms are associated with hypertensive renal disease. J Am Soc Nephrol 2008; 19: 600-614.
33. Chen Y, Rao F, Rodriguez-Flores JL, et al. Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure. Kidney Int 2008; A pr 23. [Epub ahead of print. ]
34. Wen G, Wessel J, Zhou W, et al. An ancestral variant of Secretogranin II confers regulation by PHOX2 transcription factors and association with hypertension. Hum Mol Genet 2007; 16: 1752-1764.
35. Permutt MA, Wasson J, Love-Gregory L, et al. Searching for type 2 diabetes genes on chromosome 20. Diabetes 2002; 51 (suppl 3) : S308-S315.
36. Innocenti F, Undevia SD, Iyer L, et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol 2004; 22: 1382-1388.
37. Saeki M, Saito Y, Jinno H, et al. Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing. Clin Chem 2003; 49: 1182-1185.
38. Soderback E, Zackrisson AL, Lindblom B, et al. Determination of CYP2D6 gene copy number by pyrosequencing. Clin Chem 2005; 51: 522-531.
39. Brena RM, Huang TH, Plass C. Quantitative assessment of DNA methylation: potential applications for disease diagnosis, classification, and prognosis in clinical settings. J Mol Med 2006; 84: 365-377.
40. Teodoridis JM, Hall J, Marsh S, et al. CpG island methylation of DNA damage response genes in advanced ovarian cancer. Cancer Res 2005; 65: 8961-8967.
41. Shaw RJ, Liloglou T, Rogers SN, et al. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer 2006; 94: 561-568.
42. Entz P, Toliat MR, Hampe J, et al. New strategies for efficient typing of HLA class-II loci DQB1 and DRB1 by using Pyrosequencing. Tissue Antigens 2005; 65: 67-80.
43. Hochberg EP, Miklos DB, Neuberg D, et al. A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation. Blood 2003; 101: 363-369.
44. Innings A, Krabbe M, Ullberg M, et al. Identification of 43 Streptococcus species by pyrosequencing analysis of the rnpB gene. J Clin Microbiol 2005; 43: 5983-5991.
45. Rahim A, Coutelle C, Harbottle R. High-throughput pyrosequencing of a phage display library for the identification of enriched target-specific peptides. Biotechniques 2003; 35: 317-320.
46. Jonasson J, Olofsson M, Monstein HJ. Classification, identification and subtyping of bacteria based on pyrosequencing and signature matching of 16S rDNA fragments. APMIS 2002; 110: 263-272.
47. Monstein H, Nikpour-Badr S, Jonasson J. Rapid molecular identification and subtyping of Helicobacter pylori by pyrosequencing of the 16S rDNA variable V1 and V3 regions. FEMS Microbiol Lett 2001; 199: 103-107.
48. Unnerstad H, Ericsson H, Alderborn A, et al. Pyrosequencing as a method for grouping of Listeria monocytogenes strains on the basis of single-nucleotide polymorphisms in the inlB gene. Appl Environ Microbiol 2001; 67: 5339-5342.
49. Nygren M, Reizenstein E, Ronaghi M, et al. Polymorphism in the pertussis toxin promoter region affecting the DNA-based diagnosis of Bordetella infection. J Clin Microbiol 2000; 38: 55-60.
50. Tarnberg M, Jakobsson T, Jonasson J, et al. Identification of randomly selected colonies of lactobacilli from normal vaginal fluid by pyrosequencing of the 16S rDNA variable V1 and V3 regions. APMIS 2002; 110: 802-810.
51. Gharizadeh B, Kalantari M, Garcia CA, et al. Typing of human papillomavirus by pyrosequencing. Lab Invest 2001; 81: 673-679.
52. Ronaghi M, Elahi E. Pyrosequencing for microbial typing. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 782: 67-72.
53. Elahi E, Pourmand N, Chaung R, et al. Determination of hepatitis C virus genotype by Pyrosequencing. J Virol Methods 2003; 109: 171-176.
54. Lindstrom A, Odeberg J, Albert J. Pyrosequencing for detection of lamivudine-resistant hepatitis B virus. J Clin Microbiol 2004; 42: 4788-4795.
55. Mikkelsen TS, Ku M, Jaffe DB, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007; 448: 553-560.
56. Mardis ER. The impact of next-generation sequencing technology on genetics. Trends Genet 2008; 24: 133-141.
57. Choudhuri S. The path from nuclein to human genome: a brief history of DNA with a note on human genome sequencing and its impact on future research in biology. Bull Sci Technol Soc 2003; 23: 360-367.
58. Aebersold R. A mass spectrometric journey into protein and proteome research. J Am Soc Mass Spectrom 2003; 14: 685-695.
59. Yee AA, Savchenko A, Ignachenko A, et al. NMR and X-ray crystallography, complementary tools in structural proteomics of small proteins. J Am Chem Soc 2005; 127: 16512-16517.
60. Koegl M, Uetz P. Improving yeast two-hybrid screening systems. Briefings in Functional Genomics and Proteomics 2007; 6: 302-312.
61. Templin MF, Stoll D, Schrenk M, et al. Protein microarray technology. Drug Discov Today 2002; 7: 815-822.
62. Issaq HJ. The role of separation science in proteomics research. Electrophoresis 2001; 22: 3629-3638.
63. Cho WC. Proteomics technologies and challenges. Genomics Proteomics Bioinformatics 2007; 5: 77-85.
64. Baggerman G, Vierstraete E, De Loof A, et al. Gel-based versus gel-free proteomics: a review. Comb Chem High Throughput Screen 2005; 8: 669-677.
65. Kislinger T, Gramolini AO, MacLennan DH, et al. Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue. J Am Soc Mass Spectrom 2005; 16: 1207-1220.
66. Hamdan M, Righetti PG. Modern strategies for protein quantification in proteome analysis:advantages and limitations. Mass Spectrom Rev 2002; 21: 287-302.
67. Deutsch EW, Lam H, Aebersold R. Data analysis and bioinformatics tools for tandem mass spectrometry in proteomics. Physiol Genomics 2008; 33: 18-25.
68. Cole RB. Some tenets pertaining to electrospray ionization mass spectrometry. J Mass Spectrom 2000; 35: 763-772.
69. Griffiths WJ. Nanospray mass spectrometry in protein and peptide chemistry. EXS 2000; 88: 69-79.
70. Hortin GL. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem 2006; 52: 1223-1237.
71. Steel LF, Haab BB, Hanash SM. Methods of comparative proteomic profiling for disease diagnostics. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 815: 275-284.
72. Cotter RJ. Time-of-flight mass spectrometry: an increasing role in the life sciences. Biomed Environ Mass Spectrom 1989; 18: 513-532.
73. Brancia FL. Recent developments in ion-trap mass spectrometry and related technologies. Expert Rev Proteomics 2006; 3: 143-151.
74. Wang H, Kachman MT, Schwartz DR, et al. Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers. Proteomics 2004; 4: 2476-2495.
75. Chuthapisith S, Layfield R, Kerr ID, et al. Principles of proteomics and its applications in cancer. Surgeon 2007; 5: 14-22.
76. Glish GL, Burinsky DJ. Hybrid mass spectrometers for tandem mass spectrometry. J Am Soc Mass Spectrom 2007; 19: 161-172.
77. Mirza SP, Olivier M. Methods and approaches for the comprehensive characterization and quantification of cellular proteomes using mass spectrometry. Physiol Genomics 2008; 33: 3-11.
78. Bantscheff M, Schirle M, Sweetman G, et al. Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem 2007; 389: 1017-1031.
79. Geerlof A, Brown J, Coutard B, et al. The impact of protein characterization in structural proteomics. Acta Crystallogr D Biol Crystallogr 2006; 62: 1125-1136.